| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/11/2010 | WO2010025553A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 03/11/2010 | WO2010025541A1 Identification of a conserved inner core oligosaccharide region of moraxella catarrhalis lipopolysaccharide as a vaccine antigen |
| 03/11/2010 | WO2010025505A1 Analgesia by transmucosal administration |
| 03/11/2010 | WO2010025491A1 Treatment of neonate foals with meloxicam |
| 03/11/2010 | WO2010025485A1 Use of galanthaminium bromide for producing ophthalmic formulations for treating glaucoma |
| 03/11/2010 | WO2010025482A1 Organic compounds |
| 03/11/2010 | WO2010020432A8 Compounds for treatment of duchenne muscular dystrophy |
| 03/11/2010 | WO2010011821A3 Dual-acting antihypertensive agents |
| 03/11/2010 | WO2010009065A9 Organic compounds |
| 03/11/2010 | WO2010008734A3 Methods of Preparing Imidazole-Based Bicyclic Compounds |
| 03/11/2010 | WO2010008719A3 Oral pharmaceutical formulations of vla-4 antagonists |
| 03/11/2010 | WO2010007232A9 Novel rapid-effect pharmaceutical forms and uses of resulting pharmaceutical compositions |
| 03/11/2010 | WO2010007175A3 Pacap signaling pathway modulators for treating inflammatory skin diseases with a neurogenic component, and more particularly rosacea and composition containing them |
| 03/11/2010 | WO2010007114A3 Heterocyclyl carbonic acid amides as antiproliferative agents, pdkl inhibitors |
| 03/11/2010 | WO2010005989A8 Dermatological compositions with anti-aging and skin even-toning properties |
| 03/11/2010 | WO2010005723A3 Drug loaded polymeric nanoparticles and methods of making and using same |
| 03/11/2010 | WO2010005721A3 Drug loaded polymeric nanoparticles and methods of making and using same |
| 03/11/2010 | WO2010004512A3 Dicarba-analgues of octreotide |
| 03/11/2010 | WO2010004197A3 Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof |
| 03/11/2010 | WO2010003391A3 Anionic pregnane compounds, method for their producing and use of them |
| 03/11/2010 | WO2010001349A8 Rna antagonists targeting hsp27 |
| 03/11/2010 | WO2009158431A3 Pyrimidine derivatives as kinase inhibitors |
| 03/11/2010 | WO2009158248A3 Method and compositions for improving skin and body appearance |
| 03/11/2010 | WO2009156182A3 Uracil derivatives and use thereof |
| 03/11/2010 | WO2009156099A8 6-substituted isoquinolines and isoquinolinones |
| 03/11/2010 | WO2009155041A3 Method to modulate hematopoietic stem cell growth |
| 03/11/2010 | WO2009154828A3 INHIBITORS OF RecA ACTIVITIES FOR CONTROL OF ANTIBIOTIC-RESISTANT BACTERIAL PATHOGENS |
| 03/11/2010 | WO2009154810A3 Delivery systems for multiple active agents |
| 03/11/2010 | WO2009153500A3 Plant-based compositions and uses |
| 03/11/2010 | WO2009152415A3 Reducing myocardial reperfusion injury by the combination therapy of protein kinase a activation and b1-adrenergic receptor blockade |
| 03/11/2010 | WO2009151920A9 Hepsin inhibitors |
| 03/11/2010 | WO2009151295A3 Pharmaceutical formulation comprising azelnidipine and hmg-coa reductase inhibitor or angiotensin ii receptor blocker |
| 03/11/2010 | WO2009148291A3 3- or 4-substituted piperidine compounds |
| 03/11/2010 | WO2009148290A3 3-substituted propanamine compounds |
| 03/11/2010 | WO2009148279A3 Triterpenoid-based compound used as a virus inhibitor |
| 03/11/2010 | WO2009147632A3 New compounds for the treatment of cancer |
| 03/11/2010 | WO2009146542A8 6-(c2-6alkylseleno)purines and methods for treating neural measles viral infection therewith |
| 03/11/2010 | WO2009145594A3 Drug delivery carrier |
| 03/11/2010 | WO2009143507A3 Silent desensitizers of neuronal nachr and methods of use thereof |
| 03/11/2010 | WO2009143372A3 Compositions comprising a-raf, b-raf, and c-raf sirna and methods of use thereof |
| 03/11/2010 | WO2009143133A3 Compositions and methods to protect cells by blocking entry of pathogen proteins |
| 03/11/2010 | WO2009142822A3 2-f modified rna interference agents |
| 03/11/2010 | WO2009142772A3 Methods and treatment for allergies and inflammation associated with gastrointestinal diseases |
| 03/11/2010 | WO2009142421A3 Pharmaceutical preparation (pharmaceutical formulation) |
| 03/11/2010 | WO2009141738A3 Modified drugs for use in liposomal nanoparticles |
| 03/11/2010 | WO2009141736A3 Inhibition of emmprin to treat multiple sclerosis |
| 03/11/2010 | WO2009140642A3 Tricyclic antagonists of prostaglandin d2 receptors |
| 03/11/2010 | WO2009140215A3 Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds |
| 03/11/2010 | WO2009139886A3 Targeting an hiv-1 nef-host cell kinase complex |
| 03/11/2010 | WO2009139589A3 Transnasal anticonvulsive pharmaceutical composition comprising poorly soluble anticonvulsant |
| 03/11/2010 | WO2009138582A3 Use of a composition containing 7-dehydrocholesterol or a natural extract of a vegetable or animal microorganism |
| 03/11/2010 | WO2009137843A9 Nmda receptor antagonists for the treatment of neuropsychiatric disorders |
| 03/11/2010 | WO2009134086A9 Pharmaceutical formulation for treatment of cardiovascular disease |
| 03/11/2010 | WO2009134079A9 Pharmaceutical formulation |
| 03/11/2010 | WO2009130712A3 Controlled release pharmaceutical compositions of trospium |
| 03/11/2010 | WO2009129510A4 Sulindac formulations in a biodegradable material |
| 03/11/2010 | WO2009129433A4 Alpha adrenergic receptor agonists for treatment of degenerative disc disease |
| 03/11/2010 | WO2009129120A3 Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections |
| 03/11/2010 | WO2009128964A3 Ensemble-based virtual screening reveals novel antiviral compounds for avian influenza neuraminidase |
| 03/11/2010 | WO2009127822A3 Bis-aryl compounds for use as medicaments |
| 03/11/2010 | WO2009120580A3 Methods for preventing or treating bruxism using dopaminergic |
| 03/11/2010 | WO2009118756A3 Delayed release compositions of duloxetine |
| 03/11/2010 | WO2009118567A3 Pyrimidines, triazines and their use as kinase inhibitors |
| 03/11/2010 | WO2009118411A3 3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 03/11/2010 | WO2009114716A3 Use of epicatechin and derivatives and salts thereof for cardiac protection of ischemic myocardium and to ameliorate adverse cardiac remodeling |
| 03/11/2010 | WO2009111031A3 Methods of treating vasomotor symptoms |
| 03/11/2010 | WO2009109654A3 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxcr1 and p40 |
| 03/11/2010 | WO2009095583A3 Use of aminopeptidase inhibitors or azaindole compounds for preventing or treating cancerous metastases from epithelial origin |
| 03/11/2010 | WO2009093254A3 Methods and compositions for diagnosing complications of pregnancy |
| 03/11/2010 | WO2009090453A3 Compositions comprising (r) -verapamil having mt1 receptor activity |
| 03/11/2010 | WO2009088860A3 A method of preventing contrast-induced nephropathy |
| 03/11/2010 | WO2009083972A3 Compositions and methods for enhancing the activity of podophyllotoxin |
| 03/11/2010 | WO2009080818A3 Guanidine based compounds |
| 03/11/2010 | WO2009071947A3 Potassium ion channel modulators and uses thereof |
| 03/11/2010 | WO2009066300A3 Methods and compositions for inhibiting integrins using tellurium-containing compounds |
| 03/11/2010 | WO2009060451A3 S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders |
| 03/11/2010 | WO2009060450A3 Compositions of s-alkylisothiouronium derivatives for treating upper respiratory congestion |
| 03/11/2010 | WO2009047785A9 A non-aqueous topical solution of diclofenac and process for preparing the same |
| 03/11/2010 | WO2009034432A8 Novel compounds active as muscarinic receptor antagonists |
| 03/11/2010 | WO2009026446A9 Hdac inhibitors |
| 03/11/2010 | WO2009023055A3 Blockade of the inhibitory qa-1-cd94/nkg2a pathway for treatment of autoimmune disease |
| 03/11/2010 | WO2009022215A8 Combination motif immune stimulatory oligonucleotides with improved activity |
| 03/11/2010 | WO2009012275A9 Pyridone gpr119 g protein-coupled receptor agonists |
| 03/11/2010 | WO2009004038A8 Pirenzepine and derivatives thereof as anti-amyloid agents |
| 03/11/2010 | WO2008094909A3 Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions |
| 03/11/2010 | US20100063585 Manufacture, method and use of active substance-releasing medical products for permanently keeping blood vessels open |
| 03/11/2010 | US20100063583 Use of soluble epoxide hydrolase inhibitors in the treatment of inflammatory vascular diseases |
| 03/11/2010 | US20100063260 Whitefly Ecdysone Receptor Antibody |
| 03/11/2010 | US20100063163 Extract Solution Comprising a B-Cryptoxanthin Component and Food and Drink Soaps |
| 03/11/2010 | US20100063162 Method for predicting efficacy of rar-alpha agonist |
| 03/11/2010 | US20100063161 Treatment of pervasive developmental disorders with redox-active therapeutics |
| 03/11/2010 | US20100063160 Polymorphs of o-desmethyl venlafaxine succinate |
| 03/11/2010 | US20100063159 Use of dapsone as a neuroprotector in cerebral infarction |
| 03/11/2010 | US20100063158 Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
| 03/11/2010 | US20100063157 Chemical process and new crystalline form |
| 03/11/2010 | US20100063156 Anandamide |
| 03/11/2010 | US20100063154 Polymorphs of acyl sulfonamides |
| 03/11/2010 | US20100063153 Anti-cholesterolemic compounds and methods of use |
| 03/11/2010 | US20100063152 Method and Topical Formulation for Treating Localized Edema |
| 03/11/2010 | US20100063151 Acylamide compounds having secretagogue or inducer activity of adiponectin |